Table 1 Clinicopathological parameters and HMGA2, Snail1 expression in 60 primary tongue carcinomas
From: Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway
Parameter | n | HMGA2 staining | P | Snail1 staining | P |
|---|---|---|---|---|---|
Positive (%) | Positive (%) | ||||
Age | Â | Â | 0.863 | Â | 0.134 |
 ≤55 | 34 | 22 (64.7) |  | 17 (50.0) |  |
 >55 | 26 | 15 (57.7) |  | 8 (30.8) |  |
Sex | Â | Â | 0.005 | Â | 0.394 |
 Female | 23 | 9 (39.1) |  | 8 (34.8) |  |
 Male | 37 | 28 (75.7) |  | 17 (45.9) |  |
T stage | Â | Â | 0.074 | Â | 0.895 |
 T1 + T2 | 33 | 17 (63.6) |  | 14 (45.5) |  |
 T3 + T4 | 27 | 20 (81.5) |  | 11 (59.3) |  |
Clinical stage | Â | Â | 0.001 | Â | 0.003 |
 I + II | 23 | 8 (34.8) |  | 4 (17.4) |  |
 III + IV | 37 | 29 (78.4) |  | 21 (56.8) |  |
N status | Â | Â | 0.000 | Â | 0.000 |
 N− | 35 | 14 (40.0) |  | 6 (17.1) |  |
 N+ | 25 | 23 (92.0) |  | 19 (76.0) |  |
Histological differentiation | Â | Â | 0.002 | Â | 0.001 |
 Well | 24 | 9 (37.5) |  | 4 (16.7) |  |
 Moderate/poor | 36 | 28 (77.8) |  | 21 (58.3) |  |
Survival | Â | Â | 0.000 | Â | 0.001 |
 Survival | 32 | 11 (34.4) |  | 7 (21.9) |  |
 Die | 28 | 26 (92.9) |  | 18 (64.3) |  |